The prognosis of patients with brain metastases from breast cancer is poor. Median survival after radiotherapy is 5-6 months. We report a patient in whom a complete response of a brain metastasis was induced by megestrol acetate at a daily dose of 160 mg orally.
Download full-text PDF |
Source |
|---|---|
| http://dx.doi.org/10.1097/00000421-199012000-00011 | DOI Listing |
Publication Analysis
Top Keywords
brain metastasis
8
megestrol acetate
8
complete remission
4
remission brain
4
metastasis third-line
4
third-line hormonal
4
hormonal treatment
4
treatment megestrol
4
acetate prognosis
4
prognosis patients
4
Similar Publications
Want AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!